Clinical trialNCT04802837TerminatedPhase 3Interventional

Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects

SponsorSummit TherapeuticsEnrollment2Clostridioides Difficile Infection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study to evaluate the safety of ridinilazole in adolescent subjects and how ridinilazole is metabolized.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lori Styles, MD
Summit Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Los Angeles (ucla) David Geffen School of Medicine
Los Angeles, California, United States
Children'S Hospital Orange County
Orange, California, United States
Continental Clinical Research
Miami, Florida, United States
D&h National Research Centers
Miami, Florida, United States
Dynamic Medical Research Llc
Miami, Florida, United States
Hmd Research
Orlando, Florida, United States
Children'S Center for Digestive Health
Atlanta, Georgia, United States
Snake River Research
Idaho Falls, Idaho, United States
Ann and Robert H Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
University of Chicago - Comer Children'S Hospital
Chicago, Illinois, United States
Indiana University Health - Riley Hospital for Children
Indianapolis, Indiana, United States
Boston Children'S Hospital
Boston, Massachusetts, United States
Children'S Hospital of Michigan
Detroit, Michigan, United States
Digiovanna Institute for Medical Education and Research
New York, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
University Hospitals Cleveland Medical Center - Rainbow Babies and Children'S Hospital
Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

RidinilazoleVancomycin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 May 2021
Primary completion: 17 Sept 2021
Completion: 28 Sept 2022
Last update posted: 21 Aug 2023
Registered enrollment: 2
Registry id: NCT04802837

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.